December 12, 2019
1 min read

Eylea prefilled syringe now available

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

The Eylea injection prefilled syringe is now available to order, Regeneron Pharmaceuticals announced.

The Eylea (aflibercept) 2 mg, single-dose, prefilled, sterilized syringe was approved in August to treat neovascular age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema and diabetic retinopathy.

Designed to block the growth of new blood vessels and decrease the ability of fluid to pass through blood vessels in the eye, it is the only anti-VEGF approved to treat four retinal conditions with a single dose strength prefilled syringe.